Cart
sales@molnova.com
Scyllo-Inositol
CAS No. 488-59-5
Scyllo-Inositol( Scyllitol )
Catalog No. M21272 CAS No. 488-59-5
Scyllo-Inositol is one of the inositol stereoisomers rare in the nature and expected as a promising disease-modifying therapeutic agent for Alzheimer's disease.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 32 | In Stock |
|
| 10MG | 53 | In Stock |
|
| 25MG | 85 | In Stock |
|
| 50MG | 129 | In Stock |
|
| 100MG | 206 | In Stock |
|
| 200MG | 305 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameScyllo-Inositol
-
NoteResearch use only, not for human use.
-
Brief DescriptionScyllo-Inositol is one of the inositol stereoisomers rare in the nature and expected as a promising disease-modifying therapeutic agent for Alzheimer's disease.
-
DescriptionScyllo-Inositol is one of the inositol stereoisomers rare in the nature and expected as a promising disease-modifying therapeutic agent for Alzheimer's disease.
-
In Vitro——
-
In Vivo——
-
SynonymsScyllitol
-
PathwayMembrane Transporter/Ion Channel
-
TargetBeta Amyloid
-
Recptoramyloid-β
-
Research AreaNeurological Disease
-
IndicationAlzheimer's Disease
Chemical Information
-
CAS Number488-59-5
-
Formula Weight180.16
-
Molecular FormulaC6H12O6
-
Purity>98% (HPLC)
-
SolubilityH2O:5 mg/mL (27.75 mM; Need ultrasonic)
-
SMILESO[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ibrahim T Mclaurin J A . α-Synuclein aggregation seeding and inhibition by scyllo-inositol[J]. Biochemical & Biophysical Research Communications 2015:S0006291X15310482.
molnova catalog
related products
-
V-9-M Cholecystokini...
V-9-M Cholecystokinin nonapeptide (Prepro CCK Fragment V-9-M) is a precursor compound of cholecystokinin (CCK).
-
PBD-150
PBD-150 is an inhibitor of human glutaminyl cyclase (hQC) Y115E-Y117E variant( ki : 490 nM).
-
RAGE antagonist pept...
Receptor for advanced glycation end products (RAGE) antagonist. Blocks S100P, S100A4 and HMGB-1 mediated RAGE activation in vitro and in vivo. Inhibits growth and metastasis of rat glioma tumors. Reduces cell growth and RAGE-mediated NF-κB activity in human PDAC cell lines. Inhibits effects of TDI exposure in BALB/c mice.
